Biopharmaceutical Stock Alert: Trius Therapeutics (Nasdaq:TSRX) Prices Public Offering of Common Stock
Posted on January 18, 2013 at 09:00 AM EST
SAN DIEGO - January 18, 2013 (Investorideas.com Newswire) Trius Therapeutics, Inc. (Nasdaq:TSRX) today announced the pricing of an underwritten public offering of 6,300,000 shares of its common stock at a price to the public of $4.75 per share.